These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15122088)

  • 21. Integration of the secretory control mechanisms for insulin, glucagon, and growth hormone.
    Blackard WG; Andrews SS
    Curr Top Exp Endocrinol; 1974; 2():129-53. PubMed ID: 4597978
    [No Abstract]   [Full Text] [Related]  

  • 22. Neural control of the endocrine pancreas.
    Woods SC; Porte D
    Physiol Rev; 1974 Jul; 54(3):596-619. PubMed ID: 4601624
    [No Abstract]   [Full Text] [Related]  

  • 23. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.
    Bailey CJ; Flatt PR
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():43S-50S. PubMed ID: 8299488
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin and glucagon secretion by isolated islets of Langerhans.
    Malaisse W; Leclercq-Meyer V; Malaisse-Lagae F; Mahy M
    Arch Int Physiol Biochim; 1969 Aug; 77(3):531-2. PubMed ID: 4186372
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of the gastrointestinal hormones, secretin and cholecystokinin-pancreozymin, on insulin and glucagon release in healthy and diabetic subjects.
    Raptis S; Schröder KE; Rothenbuchner G; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):769. PubMed ID: 4559420
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathobiology of the islets of Langerhans.
    Lacy PE
    Proc Inst Med Chic; 1969 May; 27(9):238-45. PubMed ID: 4894231
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulation of glucagon secretion of the diabetic pancreas in vitro [proceedings].
    Matschinsky FM; Pagliara AS
    Metabolism; 1976 Nov; 25(11 Suppl 1):1517. PubMed ID: 135912
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic endocrine functions in long-term survivors after pancreatoduodenectomy: special reference to reversibility of insulin and glucagon secretion.
    Miyata M; Yamamoto T; Hamaji M; Izukura M; Nakamura M; Taketani H; Nakao K; Kawashima Y
    World J Surg; 1988 Oct; 12(5):651-7. PubMed ID: 3072776
    [No Abstract]   [Full Text] [Related]  

  • 30. Paradoxical glucagon response after stimulation with glucose and arginine in isolated pancreatic sand rat islets.
    Ziegler M; Hahn HJ; Ziegler B; Köhler E; Fiedler H
    Diabetologia; 1975 Feb; 11(1):63-9. PubMed ID: 1095440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of immunoreactive insulin secretion in NZO mice in vivo.
    Cameron DP; Opat F; Insch S
    Diabetologia; 1974 Nov; 10 Suppl():649-54. PubMed ID: 4615027
    [No Abstract]   [Full Text] [Related]  

  • 32. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of islets of Langerhans in the utilization of energy-providing and structural substrates of food].
    Czyzyk A
    Pol Arch Med Wewn; 1975 Jun; 53(6):505-18. PubMed ID: 1094432
    [No Abstract]   [Full Text] [Related]  

  • 34. Islet transplantation into rat liver: in vitro secretion of insulin from the isolated perfused liver and in vivo glucagon suppression.
    Charles MA; Imagawa W; Forsham PH; Grodsky GM
    Endocrinology; 1976 Mar; 98(3):738-42. PubMed ID: 131032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease.
    Seino Y; Kurahachi H; Goto Y; Taminato T; Ikeda M; Imura H
    Acta Diabetol Lat; 1975; 12(2):89-99. PubMed ID: 769464
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 37. [The response of pancreatic alpha and beta cells to oral glucose stimulation in subjects with risk of diabetes].
    Ferrero E; Casale G; Ravecca D; Ricci C
    Minerva Med; 1981 Apr; 72(17):1065-70. PubMed ID: 6112718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-insulin-dependent diabetes mellitus: interplay between B-cell inadequacy and insulin resistance.
    Weir GC
    Am J Med; 1982 Oct; 73(4):461-4. PubMed ID: 6751082
    [No Abstract]   [Full Text] [Related]  

  • 39. The pathogenesis of NIDDM: the role of the pancreatic beta cell.
    Zawalich WS; Kelley GG
    Diabetologia; 1995 Aug; 38(8):986-91. PubMed ID: 7589887
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucagon and insulin secretion by islets of lean and obese (ob/ob) mice.
    Dunbar JC; Walsh MF
    Horm Metab Res; 1980 Jan; 12(1):39-40. PubMed ID: 6987139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.